3'-Deoxy-3'-18f-Fluorothymidine
3'-Deoxy-3'-18f-Fluorothymidine is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
57.1%
4 of 7 finished
42.9%
3 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Image-Guided Gynecologic Brachytherapy
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Clinical Trials (8)
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Image-Guided Gynecologic Brachytherapy
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8